Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury

Hao Zhang , Jiawan Wang , Jianghua Shen , Siqi Chen , Hailong Yuan , Xuan Zhang , Xu Liu , Ying Yu , Xinran Li , Zeyu Gao , Yaohui Wang , Jun Wang , Moshi Song

iMeta ›› 2024, Vol. 3 ›› Issue (4) : e220

PDF
iMeta ›› 2024, Vol. 3 ›› Issue (4) :e220 DOI: 10.1002/imt2.220
RESEARCH ARTICLE
Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury
Author information +
History +
PDF

Abstract

Emerging evidence has demonstrated the profound impact of the gut microbiome on cardiovascular diseases through the production of diverse metabolites. Using an animal model of myocardial ischemia–reperfusion (I/R) injury, we found that the prophylactic administration of a well-known probiotic, Bifidobacterium infantis (B. infantis), exhibited cardioprotective effects in terms of preserving cardiac contractile function and preventing adverse cardiac remodeling following I/R and that these cardioprotective effects were recapitulated by its metabolite inosine. Transcriptomic analysis further revealed that inosine mitigated I/R-induced cardiac inflammation and cell death. Mechanistic investigations elucidated that inosine suppressed the production of pro-inflammatory cytokines and reduced the numbers of dendritic cells and natural killer cells, achieved through the activation of the adenosine A2A receptor (A2AR) that when inhibited abrogated the cardioprotective effects of inosine. Additionally, in vitro studies using C2C12 myoblasts revealed that inosine attenuated cell death by serving as an alternative carbon source for adenosine triphosphate (ATP) generation through the purine salvage pathway when subjected to oxygen-glucose deprivation/reoxygenation that simulated myocardial I/R injury. Likewise, inosine reversed the I/R-induced decrease in ATP levels in mouse hearts. Taken together, our findings indicate that B. infantis or its metabolite inosine exerts cardioprotective effects against I/R by suppressing cardiac inflammation and attenuating cardiac cell death, suggesting prophylactic therapeutic options for acute ischemic cardiac injury.

Keywords

Bifidobacterium infantis / cardioprotection / inosine / myocardial ischemia–reperfusion

Cite this article

Download citation ▾
Hao Zhang, Jiawan Wang, Jianghua Shen, Siqi Chen, Hailong Yuan, Xuan Zhang, Xu Liu, Ying Yu, Xinran Li, Zeyu Gao, Yaohui Wang, Jun Wang, Moshi Song. Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury. iMeta, 2024, 3(4): e220 DOI:10.1002/imt2.220

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Timmis, Adam, Panos Vardas, Nick Townsend, Aleksandra Torbica, Hugo Katus, Delphine De Smedt, Chris P. Gale, et al. 2022. “European Society of Cardiology: Cardiovascular Disease Statistics 2021.” European Heart Journal 43: 716-799. https://doi.org/10.1093/eurheartj/ehab892

[2]

Li, Peng, Junbo Ge, and Hua Li. 2020. “Lysine Acetyltransferases and Lysine Deacetylases As Targets for Cardiovascular Disease.” Nature Reviews Cardiology 17: 96-115. https://doi.org/10.1038/s41569-019-0235-9

[3]

Zhang, Qing, Lu Wang, Shiqi Wang, Hongxin Cheng, Lin Xu, Gaiqin Pei, Yang Wang, et al. 2022. “Signaling Pathways and Targeted Therapy for Myocardial Infarction.” Signal Transduction and Targeted Therapy 7: 78. https://doi.org/10.1038/s41392-022-00925-z

[4]

Yao, Yuan, Fan Li, Mao Zhang, Li Jin, Peng Xie, Dairu Liu, Junxia Zhang, et al. 2022. “Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury By Inhibiting Myocardial Inflammation.” Circulation Research 130: 887-903. https://doi.org/10.1161/CIRCRESAHA.121.319478

[5]

Marques, Francine Z., Erin Nelson, Po-Yin Chu, Duncan Horlock, April Fiedler, Mark Ziemann, Jian K. Tan, et al. 2017. “High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.” Circulation 135: 964-977. https://doi.org/10.1161/CIRCULATIONAHA.116.024545

[6]

Yang, Yicheng, Hanwen Zhang, Yaoyao Wang, Jing Xu, Songren Shu, Peizhi Wang, and Shusi Ding, et al. 2024. “Promising Dawn In the Management of Pulmonary Hypertension: The Mystery Veil of Gut Microbiota.” iMeta 3(2), e159. https://doi.org/10.1002/imt2.159

[7]

Tang, W. H., Wilson Li, Daniel Y. Hazen, and Stanley L. Hazen. 2019. “Dietary Metabolism, the Gut Microbiome, and Heart Failure.” Nature Reviews Cardiology 16: 137-154. https://doi.org/10.1038/s41569-018-0108-7

[8]

Chen, An-Tian, Jian Zhang, and Yuhui Zhang. 2023. “Gut Microbiota in Heart Failure and Related Interventions.” iMeta 2: e125. https://doi.org/10.1002/imt2.125

[9]

Liu, Huagang, Junli Zhuang, Peng Tang, Jie Li, Xiaoxing Xiong, and Hongping Deng. 2020. “The Role of the Gut Microbiota in Coronary Heart Disease.” Current Atherosclerosis Reports 22: 77. https://doi.org/10.1007/s11883-020-00892-2

[10]

Zhao, Jinxuan, Qi Zhang, Wei Cheng, Qing Dai, Zhonghai Wei, Meng Guo, Fu Chen, et al. 2023. “Heart-Gut Microbiota Communication Determines the Severity of Cardiac Injury After Myocardial Ischaemia/Reperfusion.” Cardiovascular Research 119: 1390-1402. https://doi.org/10.1093/cvr/cvad023

[11]

Schiattarella, Gabriele Giacomo, Anna Sannino, Evelina Toscano, Giuseppe Giugliano, Giuseppe Gargiulo, Anna Franzone, Bruno Trimarco, Giovanni Esposito, and Cinzia Perrino. 2017. “Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide As Cardiovascular Risk Biomarker: A Systematic Review and Dose-Response Meta-Analysis.” European Heart Journal 38: 2948-2956. https://doi.org/10.1093/eurheartj/ehx342

[12]

Chen, Xiao-Feng, Xiangqi Chen, and Xiaoqiang Tang. 2020. “Short-Chain Fatty Acid, Acylation and Cardiovascular Diseases.” Clinical Science 134: 657-676. https://doi.org/10.1042/CS20200128

[13]

Hu, Tongtong, Qingqing Wu, Qi Yao, Kebing Jiang, Jiabin Yu, and Qizhu Tang. 2022. “Short-Chain Fatty Acid Metabolism and Multiple Effects on Cardiovascular Diseases.” Ageing Research Reviews 81: 101706. https://doi.org/10.1016/j.arr.2022.101706

[14]

Mateu-Fabregat, Javier, Hamza Mostafa, Raul Sanchez-Gimenez, Óscar M. Peiró, Gil Bonet, Anna Carrasquer, and Georgios A. Fragkiadakis, et al. 2024. “Bile Acids and Risk of Adverse Cardiovascular Events and All-Cause Mortality in Patients with Acute Coronary Syndrome.” Nutrients 16: 1062. https://doi.org/10.3390/nu16071062

[15]

Padro, Teresa, Victoria Santisteban, Pol Huedo, Montserrat Puntes, Meritxell Aguiló, Jordi Espadaler-Mazo, and Lina Badimon. 2024. “Lactiplantibacillus plantarum Strains KABP011, KABP012 and KABP013 Modulate Bile Acids and Cholesterol Metabolism in Humans.” Cardiovascular Research 120: 708-722. https://doi.org/10.1093/cvr/cvae061

[16]

Cui, Hongtu, Yanghui Chen, Ke Li, Rui Zhan, Mingming Zhao, Yangkai Xu, Zhiyong Lin, et al. 2021. “Untargeted Metabolomics Identifies Succinate As a Biomarker and Therapeutic Target in Aortic Aneurysm and Dissection.” European Heart Journal 42: 4373-4385. https://doi.org/10.1093/eurheartj/ehab605

[17]

Xu, Jing, Yicheng Yang, Xin Li, Shusi Ding, Lemin Zheng, Changming Xiong, and Yuejin Yang. 2023. “Pleiotropic Activities of Succinate: The Interplay Between Gut Microbiota and Cardiovascular Diseases.” iMeta 2: e124. https://doi.org/10.1002/imt2.124

[18]

Paik, Donggi, Lina Yao, Yancong Zhang, Sena Bae, Gabriel D. D'Agostino, Minghao Zhang, Eunha Kim, et al. 2022. “Human Gut Bacteria Produce ΤΗ17-Modulating Bile Acid Metabolites.” Nature 603: 907-912. https://doi.org/10.1038/s41586-022-04480-z

[19]

Wei, Wenchao, Chi Chun Wong, Zhongjun Jia, Weixin Liu, Changan Liu, Fenfen Ji, Yasi Pan, et al. 2023. “Parabacteroides Distasonis Uses Dietary Inulin to Suppress Nash Via Its Metabolite Pentadecanoic Acid.” Nature Microbiology 8: 1534-1548. https://doi.org/10.1038/s41564-023-01418-7

[20]

Fu, Aikun, Bingqing Yao, Tingting Dong, and Shang Cai. 2022. “Intracellular Microbes Empower Cancer Metastasis.” Life Medicine 1: 61-63. https://doi.org/10.1093/lifemedi/lnac009

[21]

Benakis, Corinne, David Brea, Silvia Caballero, Giuseppe Faraco, Jamie Moore, Michelle Murphy, Giulia Sita, et al. 2016. “Commensal Microbiota Affects Ischemic Stroke Outcome By Regulating Intestinal γδ T Cells.” Nature Medicine 22: 516-523. https://doi.org/10.1038/nm.4068

[22]

Agirman, Gulistan, Kristie B. Yu, and Elaine Y. Hsiao. 2021. “Signaling Inflammation Across the Gut-Brain Axis.” Science 374: 1087-1092. https://doi.org/10.1126/science.abi6087

[23]

Fan, Yong, and Oluf Pedersen. 2021. “Gut Microbiota in Human Metabolic Health and Disease.” Nature Reviews Microbiology 19: 55-71. https://doi.org/10.1038/s41579-020-0433-9

[24]

Abdelhamid, Ahmed Ghamry, Samar S. El-Masry, and Noha K. El-Dougdoug. 2019. “Probiotic Lactobacillus and Bifidobacterium Strains Possess Safety Characteristics, Antiviral Activities and Host Adherence Factors Revealed By Genome Mining.” EPMA Journal 10: 337-350. https://doi.org/10.1007/s13167-019-00184-z

[25]

Li, Jin, Shaoqiang Lin, Paul M. Vanhoutte, Connie W. Woo, and Aimin Xu. 2016. “Akkermansia Muciniphila Protects Against Atherosclerosis By Preventing Metabolic Endotoxemia-induced Inflammation In Apoe-/- Mice.” Circulation 133: 2434-2446. https://doi.org/10.1161/CIRCULATIONAHA.115.019645

[26]

Wu, Wenrui, Longxian Lv, Ding Shi, Jianzhong Ye, Daiqiong Fang, Feifei Guo, Yating Li, Xingkang He, and Lanjuan Li. 2017. “Protective Effect of Akkermansia Muciniphila Against Immune-Mediated Liver Injury in a Mouse Model.” Frontiers in Microbiology 8: 1804. https://doi.org/10.3389/fmicb.2017.01804

[27]

Sarkar, Amrita, and Santanu Mandal. 2016. “Bifidobacteria-Insight Into Clinical Outcomes and Mechanisms of Its Probiotic Action.” Microbiological Research 192: 159-171. https://doi.org/10.1016/j.micres.2016.07.001

[28]

Kwun, Ju-Seung, Si-Hyuck Kang, Hyo-Jung Lee, Han-Ki Park, Won-Jae Lee, Chang-Hwan Yoon, Jung-Won Suh, et al. 2020. “Comparison of Thrombus, Gut, and Oral Microbiomes in Korean Patients with ST-Elevation Myocardial Infarction: A Case-Control Study.” Experimental & Molecular Medicine 52: 2069-2079. https://doi.org/10.1038/s12276-020-00543-1

[29]

Groeger, David, Liam O'Mahony, Eileen F. Murphy, John F. Bourke, Timothy G. Dinan, Barry Kiely, Fergus Shanahan, and Eamonn M. M. Quigley. 2013. “Bifidobacterium Infantis 35624 Modulates Host Inflammatory Processes Beyond the Gut.” Gut Microbes 4: 325-339. https://doi.org/10.4161/gmic.25487

[30]

Chichlowski, Maciej, Neil Shah, Jennifer L. Wampler, Steven S. Wu, and Jon A. Vanderhoof. 2020. “Bifidobacterium Longum Subspecies Infantis (B. Infantis) in Pediatric Nutrition: Current State of Knowledge.” Nutrients 12: 1581. https://doi.org/10.3390/nu12061581

[31]

Guo, Shuangshuang, Yuming Guo, Ayla Ergun, Lei Lu, W. Allan Walker, and Kriston Ganguli. 2015. “Secreted Metabolites of Bifidobacterium Infantis and Lactobacillus Acidophilus Protect Immature Human Enterocytes from IL-1β-Induced Inflammation: A Transcription Profiling Analysis.” PLoS One 10: e0124549. https://doi.org/10.1371/journal.pone.0124549

[32]

Alexanian, Michael, Pawel F. Przytycki, Rudi Micheletti, Arun Padmanabhan, Lin Ye, Joshua G. Travers, Barbara Gonzalez-Teran, et al. 2021. “A Transcriptional Switch Governs Fibroblast Activation in Heart Disease.” Nature 595: 438-443. https://doi.org/10.1038/s41586-021-03674-1

[33]

Rurik, Joel G., István Tombácz, Amir Yadegari, Pedro O. Méndez Fernández, Swapnil V. Shewale, Li Li, Toru Kimura, et al. 2022. “CAR T Cells Produced in Vivo to Treat Cardiac Injury.” Science 375: 91-96. https://doi.org/10.1126/science.abm0594

[34]

Guo, Weiling, Qunran Xiang, Bingyong Mao, Xin Tang, Shumao Cui, Xiangfei Li, Jianxin Zhao, Hao Zhang, and Wei Chen. 2021. “Protective Effects of Microbiome-Derived Inosine on Lipopolysaccharide-Induced Acute Liver Damage and Inflammation in Mice Via Mediating the TLR4/NF-κB Pathway.” Journal of Agricultural and Food Chemistry 69: 7619-7628. https://doi.org/10.1021/acs.jafc.1c01781

[35]

Mager, Lukas F., Regula Burkhard, Nicola Pett, Noah C. A. Cooke, Kirsty Brown, Hena Ramay, Seungil Paik, et al. 2020. “Microbiome-Derived Inosine Modulates Response to Checkpoint Inhibitor Immunotherapy.” Science 369: 1481-1489. https://doi.org/10.1126/science.abc3421

[36]

Vogel, Katrin, Aditya Arra, Holger Lingel, Dirk Bretschneider, Florian Prätsch, Denny Schanze, Martin Zenker, et al. 2023. “Bifidobacteria Shape Antimicrobial T-Helper Cell Responses During Infancy and Adulthood.” Nature Communications 14: 5943. https://doi.org/10.1038/s41467-023-41630-x

[37]

Tan, Haipeng, Ya'nan Song, Jing Chen, Ning Zhang, Qiaozi Wang, Qiyu Li, Jinfeng Gao, et al. 2021. “Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling By Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury.” Advanced Science 8: e2100787. https://doi.org/10.1002/advs.202100787

[38]

Frangogiannis, Nikolaos G. 2014. “The Inflammatory Response in Myocardial Injury, Repair, and Remodelling.” Nature Reviews Cardiology 11: 255-265. https://doi.org/10.1038/nrcardio.2014.28

[39]

Fan, Qin, Rong Tao, Hang Zhang, Hongyang Xie, Lin Lu, Ting Wang, Min Su, et al. 2019. “Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury By Regulating Macrophage Polarization and Neutrophil Infiltration.” Circulation 139: 663-678. https://doi.org/10.1161/CIRCULATIONAHA.118.036044

[40]

Li, Zhenhua, Shiqi Hu, Ke Huang, Teng Su, Jhon Cores, and Ke Cheng. 2020. “Targeted Anti-IL-1beta Platelet Microparticles for Cardiac Detoxing and Repair.” Science Advances 6: eaay0589. https://doi.org/10.1126/sciadv.aay0589

[41]

Wang, Ningning, Entao Li, Huifang Deng, Lanxin Yue, Lei Zhou, Rina Su, Baokun He, et al. 2023. “Inosine: A Broad-Spectrum Anti-Inflammatory Against SARS-CoV-2 Infection-Induced Acute Lung Injury Via Suppressing TBK1 Phosphorylation.” Journal of Pharmaceutical Analysis 13: 11-23. https://doi.org/10.1016/j.jpha.2022.10.002

[42]

Welihinda, Ajith A., Manmeet Kaur, Kaviya S. Raveendran, and Edward P. Amento. 2018. “Enhancement of Inosine-Mediated A(2A)R Signaling Through Positive Allosteric Modulation.” Cellular Signalling 42: 227-235. https://doi.org/10.1016/j.cellsig.2017.11.002

[43]

Sek, Kevin, Christina Mølck, Gregory D. Stewart, Lev Kats, Phillip K. Darcy, and Paul A. Beavis. 2018. “Targeting Adenosine Receptor Signaling in Cancer Immunotherapy.” International Journal of Molecular Sciences 19: 3837. https://doi.org/10.3390/ijms19123837

[44]

Wang, Tingting, J. N. Rashida Gnanaprakasam, Xuyong Chen, Siwen Kang, Xuequn Xu, Hua Sun, Lingling Liu, et al. 2020. “Inosine Is an Alternative Carbon Source for CD8(+)-T-cell Function Under Glucose Restriction.” Nature Metabolism 2: 635-647. https://doi.org/10.1038/s42255-020-0219-4

[45]

Johnson, Todd A., H. A. Jinnah, and Naoyuki Kamatani. 2019. “Shortage of Cellular ATP As a Cause of Diseases and Strategies to Enhance ATP.” Frontiers in Pharmacology 10: 98. https://doi.org/10.3389/fphar.2019.00098

[46]

Shafy, Abdel, Vincent Molinié, Miguel Cortes-Morichetti, Vincent Hupertan, Nermine Lila, and Juan C. Chachques. 2012. “Comparison of the Effects of Adenosine, Inosine, and Their Combination As an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction.” ISRN Cardiology 2012: 326809. https://doi.org/10.5402/2012/326809

[47]

Murray, A. W. 1971. “The Biological Significance of Purine Salvage.” Annual Review of Biochemistry 40: 811-826. https://doi.org/10.1146/annurev.bi.40.070171.004115

[48]

Chen, Jun, Xinyi Chen, and Chun Loong Ho. 2021. “Recent Development of Probiotic Bifidobacteria for Treating Human Diseases.” Front Bioeng Biotechnol 9: 770248. https://doi.org/10.3389/fbioe.2021.770248

[49]

Dambrova, Maija, Coert J. Zuurbier, Vilmante Borutaite, Edgars Liepinsh, and Marina Makrecka-Kuka. 2021. “Energy Substrate Metabolism and Mitochondrial Oxidative Stress in Cardiac Ischemia/Reperfusion Injury.” Free Radical Biology and Medicine 165: 24-37. https://doi.org/10.1016/j.freeradbiomed.2021.01.036

[50]

Lopaschuk, Gary D., Qutuba G. Karwi, Rong Tian, Adam R. Wende, and E. Dale Abel. 2021. “Cardiac Energy Metabolism in Heart Failure.” Circulation Research 128: 1487-1513. https://doi.org/10.1161/CIRCRESAHA.121.318241

[51]

Cadenas, Susana. 2018. “ROS and Redox Signaling in Myocardial Ischemia-Reperfusion Injury and Cardioprotection.” Free Radical Biology and Medicine 117: 76-89. https://doi.org/10.1016/j.freeradbiomed.2018.01.024

[52]

Tian, Hao, Xiaoshuai Zhao, Yuxi Zhang, and Zhongyuan Xia. 2023. “Abnormalities of Glucose and Lipid Metabolism in Myocardial Ischemia-Reperfusion Injury.” Biomedicine & pharmacotherapy 163: 114827. https://doi.org/10.1016/j.biopha.2023.114827

[53]

Li, Tao, Zhen Zhang, Stephen C. Kolwicz, Lauren Abell, Nathan D. Roe, Maengjo Kim, Bo Zhou, et al. 2017. “Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury.” Cell Metabolism 25: 374-385. https://doi.org/10.1016/j.cmet.2016.11.005

[54]

Wang, Yuhan, Yujing Li, Chuting He, Bo Gou, and Moshi Song. 2019. “Mitochondrial Regulation of Cardiac Aging.” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865: 1853-1864. https://doi.org/10.1016/j.bbadis.2018.12.008

[55]

Headrick, John P., Ben Hack, and Kevin J. Ashton. 2003. “Acute Adenosinergic Cardioprotection in Ischemic-Reperfused Hearts.” American Journal of Physiology-Heart and Circulatory Physiology 285: H1797-H1818. https://doi.org/10.1152/ajpheart.00407.2003

[56]

Giannecchini, Michela, Marco Matteucci, Rossana Pesi, Francesco Sgarrell, Maria Grazia Tozzi, and Marcella Camici. 2005. “Uptake and Utilization of Nucleosides for Energy Repletion.” The International Journal of Biochemistry & Cell Biology 37: 797-808. https://doi.org/10.1016/j.biocel.2004.10.005

[57]

Niemann, Birte, Saskia Haufs-Brusberg, Laura Puetz, Martin Feickert, Michelle Y. Jaeckstein, Anne Hoffmann, Jelena Zurkovic, et al. 2022. “Apoptotic Brown Adipocytes Enhance Energy Expenditure Via Extracellular Inosine.” Nature 609: 361-368. https://doi.org/10.1038/s41586-022-05041-0

[58]

Wang, Jiawan, Yujing Li, Hao Zhang, Siqi Chen, Yuhan Wang, and Moshi Song. 2024. “Mitochondrial Dyshomeostasis in Cardiac Aging and Related Diseases.” Scientia Sinica Vitae 54: 260-282. https://doi.org/10.1360/SSV-2021-0366

[59]

Huang, Yan, Deying Liu, Xueyun Wei, Chensihan Huang, Changwei Li, and Huijie Zhang. 2022. “Time-Restricted Eating on Weight Loss: Implications From the TREATY Study.” Life Medicine 1: 58-60. https://doi.org/10.1093/lifemedi/lnac017

[60]

Maekawa, Yuichiro, Nobuo Mizue, Annie Chan, Yu Shi, Youan Liu, Steven Dawood, Manyin Chen, et al. 2009. “Survival and Cardiac Remodeling after Myocardial Infarction are Critically Dependent on the Host Innate Immune Interleukin-1 Receptor-Associated Kinase-4 Signaling: A Regulator of Bone Marrow-derived Dendritic Cells.” Circulation 120: 1401-1414. https://doi.org/10.1161/CIRCULATIONAHA.109.865956

[61]

Forte, Elvira, Bryant Perkins, Amalia Sintou, Harkaran S. Kalkat, Angelos Papanikolaou, Catherine Jenkins, Mashael Alsubaie, et al. 2021. “Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart.” Circulation 143: 821-836. https://doi.org/10.1161/CIRCULATIONAHA.120.044581

[62]

Wang, Jiawan, Hao Zhang, Hailong Yuan, Siqi Chen, Ying Yu, Xuan Zhang, Zeyu Gao, et al. 2024. “Prophylactic Supplementation with Lactobacillus Reuteri or Its Metabolite GABA Protects Against Acute Ischemic Cardiac Injury.” Advanced Science 11: e2307233. https://doi.org/10.1002/advs.202307233

[63]

Tang, Tony W. H., Hung-Chih Chen, Chen-Yun Chen, Christopher Y. T. Yen, Chen-Ju Lin, Ray P. Prajnamitra, Li-Lun Chen, et al. 2019. “Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.” Circulation 139: 647-659. https://doi.org/10.1161/CIRCULATIONAHA.118.035235

[64]

Jimmerson, Leah C., Lane R. Bushman, Michelle L. Ray, Peter L. Anderson, and Jennifer J. Kiser. 2017. “A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells.” Pharmaceutical Research 34: 73-83. https://doi.org/10.1007/s11095-016-2040-z

[65]

Love, Michael I., Wolfgang Huber, and Simon Anders. 2014. “Moderated Estimation of Fold Change and Dispersion for RNA-seq Data with DESeq. 2.” Genome Biology 15: 550. https://doi.org/10.1186/s13059-014-0550-8

[66]

Gou, Bo, Xiaojing Chu, Yi Xiao, Pinxuan Liu, Hao Zhang, Zeyu Gao, and Moshi Song. 2022. “Single-Cell Analysis Reveals Transcriptomic Reprogramming in Aging Cardiovascular Endothelial Cells.” Frontiers in Cardiovascular Medicine 9: 900978. https://doi.org/10.3389/fcvm.2022.900978

[67]

Damian, Doris, and Malka Gorfine. 2004. “Statistical Concerns About the GSEA Procedure.” Nature Genetics 36: 663. Author reply 663. https://doi.org/10.1038/ng0704-663a

[68]

Subramanian, Aravind, Pablo Tamayo, Vamsi K. Mootha, Sayan Mukherjee, Benjamin L. Ebert, Michael A. Gillette, Amanda Paulovich, et al. 2005. “Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles.” Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550. https://doi.org/10.1073/pnas.0506580102

[69]

Ackers-Johnson, Matthew, Peter Yiqing Li, Andrew P. Holmes, Sian-Marie O'Brien, Davor Pavlovic, and Roger S. Foo. 2016. “A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes from the Adult Mouse Heart.” Circulation Research 119: 909-920. https://doi.org/10.1161/CIRCRESAHA.116.309202

[70]

Chu, Qun, Feifei Liu, Yifang He, Xiaoyu Jiang, Yusheng Cai, Zeming Wu, Kaowen Yan, et al. 2022. “mTORC2/RICTOR Exerts Differential Levels of Metabolic Control in Human Embryonic, Mesenchymal and Neural Stem Cells.” Protein & Cell 13: 676-682. https://doi.org/10.1007/s13238-021-00898-9

RIGHTS & PERMISSIONS

2024 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/